Tech Company Financing Transactions
Ocelot Bio Funding Round
On 3/23/2022, Ocelot Bio announced $36 million in funding from RA Capital, Venrock and Vivo Capital.
Transaction Overview
Company Name
Announced On
3/23/2022
Transaction Type
Venture Equity
Amount
$36,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Undisclosed, Undisclosed
Undisclosed
Undisclosed, Undisclosed
Undisclosed
Phone
Website
Email Address
Not Recorded
Overview
Ocelot Bio, Inc., is a clinical-stage biopharmaceutical company dedicated to bringing meaningful therapeutic interventions to patients in dire need due to complications of decompensated (advanced) cirrhosis, in particular hepatorenal syndrome with acute kidney injury (HRS-AKI) and refractory ascites.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 3/23/2022: Waitroom venture capital transaction
Next: 3/23/2022: Ride1Up venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs